Nonadherence to medication is one of the major problems in treating patients with
schizophrenia. Clinicians can use a variety of assessment strategies to identify patients who …

Non‐compliance with antipsychotic medication is observed in around 50% of people with
schizophrenia and is a major preventable cause of psychiatric morbidity. A number of factors …

Objective: Despite the demonstrated efficacy of antipsychotics the relapse rate among
patients with schizophrenia remains high. One major reason for this is non‐compliance. In …

Background: Treatment nonadherence is a major obstacle in the successful management of
schizophrenia. Finding out factors associated with nonadherence and the reasons for …

BACKGROUND: Despite the fact that medication adherence is among the most important
health related behaviors in relapse prevention and recovery in schizophrenia, it is often not …

BACKGROUND: The Health Belief Model states that medication adherence is primarily
determined by beliefs (ie, perceptions of: adherence costs and benefits, susceptibility, and …

This review evaluates the impact of partial compliance on treatment outcomes in
schizophrenia and discusses strategies that may be implemented to enhance compliance …

OBJECTIVE: The primary aim of this study was to compare electronic monitoring with other
measures of adherence to antipsychotic medication in outpatients with schizophrenia. The …

It has remained unclear what factors relate to primary nonadherence to antipsychotic
treatment and whether specific agents and routes of administration differ in how patients …

Poor adherence to medication can have devastating consequences for patients with serious
mental illness. The literature review and recommendations in this article are reprinted from …